This article is more than 5 years old. Information may no longer be current.

RSB Spine LLC announces European patent allowance

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

RSB Spine LLC has announced allowance of European patent 1847240, covering specific design iterations of its line of InterPlate cervical and lumbar intervertebral fusion devices.

"Fusion remains one of the most common spinal procedures performed by neurosurgeons and orthopedic surgeons, despite the introduction of numerous disc replacement implants," James M. Moran, D. Eng., chief technical officer of RSB Spine, stated in a company release. "This intellectual property reinforces RSB's freedom to respond to evolving surgeon preferences and supports our plans for European sales. Ongoing legal disputes also highlight the need for medical device companies to have the protection of a strong patent portfolio."

In July, the company received a United States patent involving design of interbody devices that prevent stress shielding, complementing a previous European approval for the same concepts.